Xethanol Extends Research Agreement with NREL on Ethanol Feedstocks

Xethanol Corporation, a renewable energy and clean technology company, today announced an extension of its Cooperative Research and Development Agreement (CRADA) on cellulosic ethanol feedstocks, with the National Renewable Energy Laboratory (NREL) in Golden, Colorado. The agreement has been extended through March 7, 2008. The NREL lab is operated by the Midwest Research Institute under contract to the US Department of Energy.

"Extending this CRADA with Xethanol is another step the National Renewable Energy Laboratory is taking to develop the technologies that will help the nation meet presidential and Department of Energy goals of reducing the country’s dependence on imported oil," NREL Commercialization Manager Richard Bolin said.

The original agreement dates back to January 2005, for work directed toward a method of biomass feedstock separation. The research focuses specifically on clean fractionation of cellulosic feedstocks into their component parts.

Xethanol is focusing on opportunities in renewable energy and clean technology, including biomass gasification for electricity production, wind power, solar power, energy storage, energy infrastructure, energy efficiency, waste recycling and agricultural processes. These sectors aim to provide profitable solutions to global challenges.

The CRADA with NREL is part of Xethanol’s portfolio of research and consulting agreements on renewable energy with some of the nation’s leading research institutions including Virginia Tech in Blacksburg, Virginia; the Forest Products Lab of the US Department of Agriculture, in Madison, Wisconsin; the USDA in Winter Haven, Florida, and the Energy and Environmental Research Lab in Grand Forks, North Dakota.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.